1. Home
  2. LSTA vs ORIS Comparison

LSTA vs ORIS Comparison

Compare LSTA & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • ORIS
  • Stock Information
  • Founded
  • LSTA 1980
  • ORIS 2014
  • Country
  • LSTA United States
  • ORIS China
  • Employees
  • LSTA N/A
  • ORIS N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • ORIS Farming/Seeds/Milling
  • Sector
  • LSTA Health Care
  • ORIS Consumer Staples
  • Exchange
  • LSTA Nasdaq
  • ORIS Nasdaq
  • Market Cap
  • LSTA 31.2M
  • ORIS 30.4M
  • IPO Year
  • LSTA N/A
  • ORIS 2024
  • Fundamental
  • Price
  • LSTA $2.61
  • ORIS $1.14
  • Analyst Decision
  • LSTA Strong Buy
  • ORIS
  • Analyst Count
  • LSTA 1
  • ORIS 0
  • Target Price
  • LSTA $15.00
  • ORIS N/A
  • AVG Volume (30 Days)
  • LSTA 66.3K
  • ORIS 321.3K
  • Earning Date
  • LSTA 02-27-2025
  • ORIS 02-21-2025
  • Dividend Yield
  • LSTA N/A
  • ORIS N/A
  • EPS Growth
  • LSTA N/A
  • ORIS N/A
  • EPS
  • LSTA N/A
  • ORIS 0.43
  • Revenue
  • LSTA N/A
  • ORIS $16,745,999.00
  • Revenue This Year
  • LSTA N/A
  • ORIS N/A
  • Revenue Next Year
  • LSTA N/A
  • ORIS N/A
  • P/E Ratio
  • LSTA N/A
  • ORIS $2.65
  • Revenue Growth
  • LSTA N/A
  • ORIS N/A
  • 52 Week Low
  • LSTA $2.19
  • ORIS $1.12
  • 52 Week High
  • LSTA $4.20
  • ORIS $21.24
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • ORIS N/A
  • Support Level
  • LSTA $2.45
  • ORIS N/A
  • Resistance Level
  • LSTA $2.74
  • ORIS N/A
  • Average True Range (ATR)
  • LSTA 0.32
  • ORIS 0.00
  • MACD
  • LSTA -0.05
  • ORIS 0.00
  • Stochastic Oscillator
  • LSTA 16.48
  • ORIS 0.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is a company who is an integrated supplier of tea products in Mainland China. Their major tea products include primarily-processed tea consisting of white tea and black tea, and refined white tea and black tea. Its business operations are vertically integrated, covering cultivation, processing of tea leaves and the sale of tea products to tea business operators (such as wholesale distributors) and end-user retail customers in Mainland China.

Share on Social Networks: